Welcome to the 9th Advanced RWE Applications in Pharma
Creating Value for Patients through Extrapolating Real-World Clinical & Behavioral Data
Returning for its 9th year, Advanced Real-World Evidence Applications in Pharma 2021 (formerly IMPACCT: RWE) will assist pharma and biotech leaders in transforming real-world evidence into business intelligence, impacting your pipeline, and delivering patient outcomes.
This comprehensive industry-led forum is dedicated to revolutionizing novel treatment development through RWE applications: re-strategizing clinical programs, maximizing product lifecycles, and minimizing risks.
Across 3 days, you can expect 18+ practical case studies and a collaborative, open discussion to accelerate your implementation of real-world evidence approaches to enhance clinical R&D outcomes, de-risk clinical trials, and maximize product lifecycle.
What’s New in 2021?
2020 was an exciting year for real-world data (RWD) and real-world evidence (RWE) experts within pharma and biotech. The FDA’s high-profile acceptance of RWD as part of their review for COVID-19 treatments and vaccines for emergency use authorization was a big moment for the industry. This is now energizing RWD and RWE into R&D and clinical activities – expediting novel treatments for patients and substantially reducing drug developers’ R&D spend.
However, major questions still need answers urgently. The 9th Advanced Real-World Evidence Applications in Pharma will return in October 2021 to delve into the core industry challenges, including:
- Assessing the global regulatory environment for future RWE application
- Advanced data acquisition and analytics to enable your R&D and clinically informed decision making
- Leverage RWE in your clinical activities – from patient selection to synthetic trial arm
- How to create a robust, regulatory-compliant RWE framework and data package for your successful IND filing
- Maximizing your product lifecycle through a comprehensive observational data program
Establishing pre-competitive collaboration to deepen your understanding of diseases, offering patients a personalized and effective treatment through RWE & RWD
Your Expert Speakers
Eric Sarpong
Director Real World Data Analytics & Innovation, Center for Observational & Real World Evidence
Merck
Kraig Kinchen
Senior Director, Center of Expertise, Global Patient Outcomes & Real World Evidence
Eli Lilly
What people thought at the 8th IMPACCT: RWE
"Perfect! I would like to see IMPACTT:RWE next year again”
Past Attendee
“Great insight of the RWE environment”
Past Attendee
